A Retrospective Investigation of the Relationship betweenNeuroblastoma Response to
Cancer Therapy and Exposure to Opioids for Pain Management
Kyle Morgan, MD, St. Jude Children’s Research Hospital, Memphis, TN,
USA,
Andrew Dudas, St. Jude Children’s Research Hospital, Memphis, TN, USA,
Wayne Furman, St. Jude Children’s Research Hospital, Memphis, TN, USA,
Beth McCarville, St. Jude Children’s Research Hospital, Memphis, TN,
USA,
Barry Shulkin, St. Jude Children’s Research Hospital, Memphis, TN, USA,
Zhaohua Lu, Biostatistician, St. Jude Children’s Research Hospital,
Memphis, TN, USA,
Himani Darji, Biostatistician, St. Jude Children’s Research Hospital,
Memphis, TN, USA and
Doralina L. Anghelescu, St. Jude Children’s Research Hospital, Memphis,
TN, USA.
Corresponding Author: Doralina Anghelescu, MS 130, Room IA5302, St. Jude
Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, USA
38105-3678, Phone: (901) 595-4034, Fax: (901) 595-4061, Email:
doralina.anghelescu@stjude.org
Abstract: 201 words
Manuscript: 2,489 words
Tables, Figures and Supporting Files: 3
Running Title: Effect of Opioids on Neuroblastoma Therapy Response
Key words: Opioid, pain, anti-GD2 mAb, pediatric, hematology, tumor
volume ratio